Organization model for allotransplantations of cryopreserved
vascular grafts in Czech Republic

J 2018

Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic

ŠPAČEK, Miroslav, Pavel SMĚŘIČKA, Libor JANOUŠEK, Petr ŠTÁDLER, Miloš ADAMEC et. al.

Basic information

Original name

Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic

Authors

ŠPAČEK, Miroslav (203 Czech Republic, guarantor), Pavel SMĚŘIČKA (203 Czech Republic), Libor JANOUŠEK (203 Czech Republic), Petr ŠTÁDLER (203 Czech Republic), Miloš ADAMEC (203 Czech Republic), Robert VLACHOVSKÝ (203 Czech Republic, belonging to the institution), Igor GUŇKA (203 Czech Republic), Pavel NAVRÁTIL (203 Czech Republic), Filip THIEME (203 Czech Republic), Petr MITÁŠ (203 Czech Republic), Rudolf ŠPUNDA (203 Czech Republic), Jaroslav ŠPATENKA (203 Czech Republic), Robert STAFFA (203 Czech Republic, belonging to the institution), Petr NĚMEC (203 Czech Republic) and Jaroslav LINDNER (203 Czech Republic)

Edition

Cell and Tissue Banking, Dordrecht, Springer, 2018, 1389-9333

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

10601 Cell biology

Country of publisher

Netherlands

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 1.939

RIV identification code

RIV/00216224:14110/18:00104200

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1007/s10561-018-9691-4

UT WoS

000442599400018

Keywords in English

Vascular allograft; Cryopreservation; Tissue transplantation; Organization model

Abstract

V originále

The transplantation of fresh or cryopreserved vascular allografts in patients with a prosthetic graft infection or critical limb ischemia is necessary for their limb salvage and, in many cases, represents a lifesaving procedure. While transplantation of fresh allografts has a long history in the Czech Republic, the standard use of cryopreserved vascular allografts was introduced into the clinical practice in 2011 as a result of the implementation of EU Directive 2004/23/EC into national legislation (Human Cell and Tissue Act No. 296/2008 Coll.). The authors present an organizational model based on cooperation between the majority of Czech Transplant Centers with a tissue establishment licensed by the national competent authority. In various points, we are addressing individual aspects of experimental and clinical studies which affect clinical practice. Based on experimental and clinical work, the first validation of cryopreserved arterial and venous grafts for clinical use was performed between 2011 and 2013. The growing number of centers participating in this programme led to a growing number of patients who underwent transplantation of vascular allografts. In 2015 the numbers of transplanted fresh versus cryopreserved allografts in the Czech Republic were almost equal. Cooperation of the participating centers in the Czech Republic with the licensed Tissue Establishment made it possible to achieve a full compliance with the European Union Directives, and harmonized national legal norms and assured a high quality of cryopreserved vascular allografts.

Citovat

ŠPAČEK, Miroslav, Pavel SMĚŘIČKA, Libor JANOUŠEK, Petr ŠTÁDLER, Miloš ADAMEC, Robert VLACHOVSKÝ, Igor GUŇKA, Pavel NAVRÁTIL, Filip THIEME, Petr MITÁŠ, Rudolf ŠPUNDA, Jaroslav ŠPATENKA, Robert STAFFA, Petr NĚMEC and Jaroslav LINDNER. Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic. Cell and Tissue Banking. Dordrecht: Springer, 2018, vol. 19, No 3, p. 437-445. ISSN 1389-9333. Available from: https://dx.doi.org/10.1007/s10561-018-9691-4.

@article{1455336,
   author = {Špaček, Miroslav and Směřička, Pavel and Janoušek, Libor and Štádler, Petr and Adamec, Miloš and Vlachovský, Robert and Guňka, Igor and Navrátil, Pavel and Thieme, Filip and Mitáš, Petr and Špunda, Rudolf and Špatenka, Jaroslav and Staffa, Robert and Němec, Petr and Lindner, Jaroslav},
   article_location = {Dordrecht},
   article_number = {3},
   doi = {http://dx.doi.org/10.1007/s10561-018-9691-4},
   keywords = {Vascular allograft; Cryopreservation; Tissue transplantation; Organization model},
   language = {eng},
   issn = {1389-9333},
   journal = {Cell and Tissue Banking},
   title = {Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic},
   volume = {19},
   year = {2018}
}

TY  - JOUR
ID  - 1455336
AU  - Špaček, Miroslav - Směřička, Pavel - Janoušek, Libor - Štádler, Petr - Adamec, Miloš - Vlachovský, Robert - Guňka, Igor - Navrátil, Pavel - Thieme, Filip - Mitáš, Petr - Špunda, Rudolf - Špatenka, Jaroslav - Staffa, Robert - Němec, Petr - Lindner, Jaroslav
PY  - 2018
TI  - Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic
JF  - Cell and Tissue Banking
VL  - 19
IS  - 3
SP  - 437-445
EP  - 437-445
PB  - Springer
SN  - 13899333
KW  - Vascular allograft
KW  - Cryopreservation
KW  - Tissue transplantation
KW  - Organization model
N2  - The transplantation of fresh or cryopreserved vascular allografts in patients with a prosthetic graft infection or critical limb ischemia is necessary for their limb salvage and, in many cases, represents a lifesaving procedure. While transplantation of fresh allografts has a long history in the Czech Republic, the standard use of cryopreserved vascular allografts was introduced into the clinical practice in 2011 as a result of the implementation of EU Directive 2004/23/EC into national legislation (Human Cell and Tissue Act No. 296/2008 Coll.). The authors present an organizational model based on cooperation between the majority of Czech Transplant Centers with a tissue establishment licensed by the national competent authority. In various points, we are addressing individual aspects of experimental and clinical studies which affect clinical practice. Based on experimental and clinical work, the first validation of cryopreserved arterial and venous grafts for clinical use was performed between 2011 and 2013. The growing number of centers participating in this programme led to a growing number of patients who underwent transplantation of vascular allografts. In 2015 the numbers of transplanted fresh versus cryopreserved allografts in the Czech Republic were almost equal. Cooperation of the participating centers in the Czech Republic with the licensed Tissue Establishment made it possible to achieve a full compliance with the European Union Directives, and harmonized national legal norms and assured a high quality of cryopreserved vascular allografts.
ER  -

ŠPAČEK, Miroslav, Pavel SMĚŘIČKA, Libor JANOUŠEK, Petr ŠTÁDLER, Miloš ADAMEC, Robert VLACHOVSKÝ, Igor GUŇKA, Pavel NAVRÁTIL, Filip THIEME, Petr MITÁŠ, Rudolf ŠPUNDA, Jaroslav ŠPATENKA, Robert STAFFA, Petr NĚMEC and Jaroslav LINDNER. Organization model for allotransplantations of cryopreserved vascular grafts in Czech Republic. \textit{Cell and Tissue Banking}. Dordrecht: Springer, 2018, vol.~19, No~3, p.~437-445. ISSN~1389-9333. Available from: https://dx.doi.org/10.1007/s10561-018-9691-4.

Detailed Information on Publication Record